Sovereign Wealth Capital Invests in Moximed

Posted on 03/16/2017


Hayward, California-based Moximed, Inc., a developer of unicompartmental load absorber implants for active patients with painful knee osteoarthritis (OA), raised a US$ 50 million Series C round. New investors that joined the round are London-based Advent Life Sciences LLP and Australia’s Future Fund. Other existing investors have joined the Series C round include New Enterprise […]